Stockwatch

Date	Sym	Company	Price	Type	Headline
2023-05-17 12:04	CC:RVX	Resverlogix Corp	0.13	Warrants Expire110	Resverlogix warrants to expire June 7
2023-05-11 18:11	CC:RVX	Resverlogix Corp	0.14	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2023-05-11 18:11	CC:RVX	Resverlogix Corp	0.14	SEDAR MD & A815	SEDAR MD & A
2023-03-31 19:28	CC:RVX	Resverlogix Corp	0.145	SEDAR MD & A815	SEDAR MD & A
2023-03-31 19:26	CC:RVX	Resverlogix Corp	0.145	SEDAR Audited Annual Financial Statements804	SEDAR Audited Annual Financial Statements
2023-03-31 19:20	CC:RVX	Resverlogix Corp	0.145	SEDAR Annual Information Form802	SEDAR Annual Information Form
2023-03-20 11:49	CC:RVX	Resverlogix Corp	0.16	News Release200	Resverlogix closes one-year extension of debenture
2023-03-02 13:15	CC:RVX	Resverlogix Corp	0.155	News Release200	Resverlogix publishes 2 articles in scientific journals
2022-11-11 18:06	CC:RVX	Resverlogix Corp	0.19	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2022-11-11 18:06	CC:RVX	Resverlogix Corp	0.19	SEDAR MD & A815	SEDAR MD & A
2022-09-28 10:45	CC:RVX	Resverlogix Corp	0.205	News Release200	Resverlogix to focus apabetalone work on long COVID
2022-08-22 10:08	CC:RVX	Resverlogix Corp	0.25	News Release200	Resverlogix publishes apabetalone data in journal
2022-08-15 18:48	CC:RVX	Resverlogix Corp	0.27	News Release200	Resverlogix adds Kulikowski as chief scientific officer
2022-08-12 19:09	CC:RVX	Resverlogix Corp	0.265	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2022-08-12 19:09	CC:RVX	Resverlogix Corp	0.265	SEDAR MD & A815	SEDAR MD & A
2022-06-22 01:21	CC:RVX	Resverlogix Corp	0.26	News Release200	Resverlogix shareholders approve all AGM resolutions
2022-06-08 10:20	CC:RVX	Resverlogix Corp	0.22	News Release200	Resverlogix talks BD2-selective BET inhibitor safety